Navigation Links
UNT Health Science Center's Groundbreaking Research Applied to Protecting Brain After Traumatic Injury
Date:7/3/2009

FORT WORTH, Texas, July 3 /PRNewswire-USNewswire/ -- In groundbreaking research, scientists at the University of North Texas Health Science Center at Fort Worth have determined that rapid estrogen administration can protect the brain following brain injury. These findings are now being tested on human trauma patients in North Texas.

James Simpkins, Ph.D., UNT Health Science Center chair of the Department of Pharmacology and Neuroscience, and Jane Wigginton, M.D., Department of Surgery, Division of Emergency Medicine at UT Southwestern Medical Center of Dallas, are translating these animal studies of the protective effects of rapid estrogen treatment to human patients with severe traumatic brain injury and hemorrhagic shock.

"Our animal research has demonstrated that rapid estrogen intervention protects the brain following injury, including stroke or sudden cardiac arrest," Simpkins said. "Now, UT Southwestern and Parkland Health and Hospital System are advancing our research from the UNT Health Science Center to these studies in human subjects. If we can administer these drugs to trauma victims very early, I believe that we can protect the brain and increase survival."

Simpkins' studies in animals found that rapidly administering a single dose of estrogen, a strong anti-oxidant and an anti-inflammatory drug, following a stroke increases brain cell survival by up to 65 percent. Estrogens delivered intravenously post injury may have similar effects on people with traumatic brain injury. "We know these substances can protect the brain and believe them safe for use in this patient population," Simpkins said.

The clinical trials are based on now hundreds of scientific publications from Simpkins' group and others demonstrating the protective effects of estrogens in acute brain injury. Simpkins leads a large National Institutes of Health-funded program of research to discover substances that can protect the brain from injury. This is the first major clinical study to emanate from these basic science studies at the University of North Texas Health Science Center at Fort Worth.

Estrogens are made in large amounts by young women, but only in small amounts by men. Prior studies have suggested that young women are more resistant to brain trauma injury than are older, post-menopausal women and men. This apparent resistance of young women to brain trauma may be because of their higher estrogen levels. These current studies of the effects of rapid estrogen administration on patients with traumatic brain injury and hemorrhagic shock will be a test of this proposal.

In 1994, Simpkins discovered that estrogens were protective to nerve cells and subsequently has demonstrated that, if administered soon after brain injury in animals, estrogens can protect nerve cells and reduce neurological deficits. Application of these discoveries to human subjects awaited the interactions of Simpkins with the pioneering clinical research of Wigginton, who is now the first to take estrogens into clinical trials for acute brain injury and hemorrhagic shock.

University of North Texas Health Science Center

The University of North Texas Health Science Center comprises the Texas College of Osteopathic Medicine, the Graduate School of Biomedical Sciences, the School of Public Health, and the School of Health Professions. Key research areas include aging and Alzheimer's disease, cancer and physical medicine. This year, the Texas College of Osteopathic Medicine was named a top 50 medical school in primary care by U.S. News & World Report for the eighth consecutive year. "Fort Worth's medical school and more" contributes more than $400 million to the Tarrant County and Texas economies annually. For more information, go to http://www.hsc.unt.edu/.


'/>"/>
SOURCE University of North Texas Health Science Center/Fort Worth
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Md. , Feb. 4, 2016 In response ... , the FDA,s Deputy Commissioner for Medical Products and Tobacco, ... plan to reassess the agency,s approach to opioid medications. The ... while still providing patients in pain access to effective relief. ... FDA will: , Re-examine the risk-benefit paradigm for ...
(Date:2/4/2016)...  Blueprint Medicines Corporation (NASDAQ: BPMC ), ... investigational kinase medicines for patients with genomically defined ... of directors of Lonnel Coats , a ... industry-related experience. Jeffrey Albers , ... strategic experience developing and commercializing numerous oncology products ...
(Date:2/4/2016)... , Feb. 4, 2016 SONIFI™ Health, ... solutions, today announced that MonteCedro, an innovative retirement ... Engagement System. The system provides a simple and ... access through a tablet PC. ... engagement system provides access to a wide spectrum ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... , ... US Sports Camps , official operators of Nike Yoga Camps, ... yoga training. ChildLight Yoga Studio is centrally situated in the picturesque New England city ... Studio founder Lisa Flynn expresses her excitement, “We are thrilled to be partnering with ...
(Date:2/5/2016)... , ... February 05, 2016 , ... The American public ... such water may be safer than regular municipal or well water. The recent experience ... host Sharon Kleyne, could go a long way toward increasing public acceptance of recycled ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure today announced ... and donate to Give To Cure’s campaign that is crowdfunding clinical trials to help ... and share payments through a smart device. In 2015 alone, Venmo processed $7.5 billion ...
(Date:2/5/2016)... ... 2016 , ... Pivot Point Consulting, a leading national Healthcare ... Services for HIT Implementation Support & Staffing report with an outstanding score of ... healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. , ...
(Date:2/5/2016)... ... February 05, 2016 , ... Dr. Justin Scott and Dr. Lydia Muccioli ... Cost Dental Day to individuals in need. The event is scheduled to take place ... Dental Day is to provide dental care to community members in need. Each patient ...
Breaking Medicine News(10 mins):